Norgestimate
From Wikipedia, the free encyclopedia
| This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (February 2007) |
| Systematic (IUPAC) name | |
|---|---|
| (13-ethyl-17-ethynyl-3-hydroxyimino- 1,2,6,7,8,9,10,11,12,14,15,16- dodecahydrocyclopenta[a] phenanthren-17-yl) acetate | |
| Clinical data | |
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
| MedlinePlus | a601050 |
| Pregnancy cat. | ? |
| Legal status | ? |
| Pharmacokinetic data | |
| Half-life | 12-30 hours |
| Identifiers | |
| CAS number | 35189-28-7 |
| ATC code | G03AA11 |
| PubChem | CID 6540478 |
| DrugBank | APRD00569 |
| ChemSpider | 5022837 |
| UNII | C291HFX4DY |
| KEGG | D05209 |
| ChEBI | CHEBI:50815 |
| ChEMBL | CHEMBL1200934 |
| Chemical data | |
| Formula | C23H31NO3 |
| Mol. mass | 369.497 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
Norgestimate is a molecule used in hormonal contraceptives.
Norgestimate is a form of progesterone, which is a female hormone important for the regulation of ovulation and menstruation. Norgestimate is used with estradiol (a female sex hormone that is involved in the development and maintenance of the female reproductive system), to treat the symptoms of menopause.
[edit] See also
|
||||||||||||||||||||||||||||||||||||||||||||||||
| This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |